Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease

Movement Disorders

Volumn 24, Issue 3, 2009, Pages 429-433

  Rakovic, Aleksandar ^a   Stiller, Barbara ^b   Djarmati, Ana ^a   Flaquer, Antonia ^c,g   Freudenberg, Jan ^d   Toliat, Mohammad Reza ^b,e   Linnebank, Michael ^c   Kostic, Vladimir ^f   Lohmann, Katja ^a   Paus, Sebastian ^c   Nürnberg, Peter ^b,e   Kubisch, Christian ^b,e   Klein, Christine ^a   Wüllner, Ullrich ^c   Ramirez, Alfredo ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF COLOGNE   (Germany)

^f UNIVERSITY OF BELGRADE   (Serbia)

^g PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Association study; ATP13A2; Parkinson's disease; Parkinsonism

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE 13A2; UNCLASSIFIED DRUG; ATP13A2 PROTEIN, HUMAN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; MIDDLE AGED;

ADULT; AGE OF ONSET; AGED; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTON-TRANSLOCATING ATPASES;

EID: 67651107343     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22399     Document Type: Article

References (21)

1. Lang AE, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med 1998;339:1130-1143.
2. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998;339:1044-1053.
3. Klein C, Schlossmacher MG. Parkinson's disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Neurology 2007;69:2093-2104.
4. Schrag A, Schott JM. Epidemiological, clinical, and genetic characteristics of early-onset Parkinsonism. Lancet Neurol 2006;5: 355-363.
5. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 2005;6:79-87.
6. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003;302:819-822.
7. Selkoe DJ. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 2004;6: 1054-1061.
8. Ramirez A, Heimbach A, Grundemann J, et al. Hereditary Parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 2006;38: 1184-1191.
9. Williams DR, Hadeed A, al-Din AS, Wreikat AL, Lees AJ. Kufor Rakeb disease: autosomal recessive, levodopa-responsive Parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Mov Disord 2005;20:1264-1271.
10. Najim al-Din AS, Wriekat A, Mubaidin A, Dasouki M, Hiari M. Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurol Scand 1994;89: 347-352.
11. Di Fonzo A, Chien HF, Socal M, et al. ATP13A2 missense mutations in juvenile Parkinsonism and young onset Parkinson's disease. Neurology 2007;68:1557-1562.
12. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993;39: 165-172.
13. Zhang K, Qin Z, Chen T, Liu JS, Waterman MS, Sun F. Hap-Block: haplotype block partitioning and tag SNP selection software using a set of dynamic programming algorithms. Bioinformatics 2005;21:131-134.
14. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005;76:887-893.
15. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
16. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150.
17. Fung HC, Scholz S, Matarin M, et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2006;5: 911-916.
18. Maraganore DM, de Andrade M, Lesnick TG, et al. High-resolution whole-genome association study of Parkinson's disease. Am J Hum Genet 2005;77:685-693.
19. Ross OA, Haugarvoll K, Stone JT, et al. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism Relat Disord 2007;13:386-388.
20. Schlitter AM, Kurz M, Larsen JP, et al. Parkin gene variations in late-onset Parkinson's disease: comparison between Norwegian and German cohorts. Acta Neurol Scand 2006;113:9-13.
21. Maraganore DM, de Andrade M, Elbaz A, et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson's disease. JAMA 2006;296:661-670.